Diagnostic Approach to Cardiomegaly

Initial Evaluation

The European Society of Cardiology recommends performing a 12-lead ECG and transthoracic echocardiography (TTE) in all patients with suspected cardiomegaly to confirm cardiac dysfunction and determine left ventricular ejection fraction 1, 2, 3
A completely normal ECG has a negative predictive value exceeding 90% for excluding left ventricular systolic dysfunction, with the American Heart Association noting its importance in initial assessment 1, 3
The European Heart Journal suggests that TTE is the preferred method for confirming cardiac dysfunction, providing critical information on left ventricular ejection fraction, wall thickness, valvular function, and diastolic filling patterns 4, 1, 3
Echocardiography is essential to assess for left ventricular hypertrophy, with a wall thickness of ≥15 mm suggesting hypertrophic cardiomyopathy in adults, according to the European Society of Cardiology 4, 1, 3
The American College of Cardiology recommends obtaining a chest X-ray in two planes to assess for cardiomegaly, pulmonary congestion, and pleural effusions, with a caveat that cardiomegaly can be absent on chest X-ray even in chronic heart failure 1, 2, 3
Measuring BNP or NT-proBNP can help exclude heart failure, with the European Society of Cardiology noting that BNP <35 pg/mL or NT-proBNP <125 pg/mL makes chronic heart failure unlikely 1, 2

The American Heart Association suggests considering cardiac magnetic resonance (CMR) when echocardiography is inconclusive or technically limited, particularly for detecting myocardial fibrosis and assessing wall thickness in difficult-to-image segments 4, 5
CMR is valuable for evaluating infiltrative diseases like amyloidosis, with the European Heart Journal recommending its use in such cases 4, 5
Cardiac CT can be used when both echocardiography is limited and CMR is contraindicated or unavailable, according to the American College of Cardiology 8

For suspected hypertrophic cardiomyopathy, the European Society of Cardiology recommends performing a systematic search for underlying cause, including specialized laboratory testing, and screening for Fabry disease, Danon disease, and amyloidosis 5
The American Heart Association suggests considering genetic testing in patients fulfilling diagnostic criteria for HCM to enable cascade screening of relatives 5
For suspected ischemic cardiomyopathy, the European Society of Cardiology recommends considering coronary angiography, stress echocardiography, or nuclear perfusion studies 1, 3

The European Heart Journal warns against relying solely on chest X-ray, as cardiomegaly may be absent on imaging despite significant cardiac dysfunction 1, 2
The American College of Cardiology advises against dismissing the diagnosis with a normal echocardiogram alone, considering diastolic dysfunction, which requires specific Doppler assessment 6, 3
The European Society of Cardiology recommends screening for reversible causes, such as thyroid disease, anemia, and drug-induced cardiomyopathy, as these are potentially treatable 1, 2, 5